Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 714 | 1,216 | 615 | 1,226 | 1,004 |
| Cost of Goods | 207 | 181 | 183 | 160 | 170 |
| Gross Profit | 507 | 1,036 | 432 | 1,066 | 834 |
| Operating Expenses | 10,916 | 9,333 | 8,994 | 8,285 | 6,950 |
| Operating Income | -10,202 | -8,117 | -8,380 | -7,059 | -5,947 |
| Interest Expense | -1 | -1 | -1 | 0 | 0 |
| Other Income | -55 | -80 | -30 | -94 | 23 |
| Pre-tax Income | -10,256 | -8,196 | -8,409 | -7,154 | -5,924 |
| Net Income Continuous | -10,256 | -8,196 | -8,409 | -7,154 | -5,924 |
| Minority Interests | -1,253 | -646 | -689 | -1,117 | -966 |
| Net Income | $-9,003 | $-7,550 | $-7,719 | $-6,037 | $-4,958 |
| EPS Basic Total Ops | -0.16 | -0.14 | -0.15 | -0.13 | -0.10 |
| EPS Basic Continuous Ops | -0.18 | -0.15 | -0.16 | -0.15 | -0.12 |
| EPS Diluted Total Ops | -0.16 | -0.14 | -0.15 | -0.13 | -0.10 |
| EPS Diluted Continuous Ops | -0.18 | -0.15 | -0.16 | -0.15 | -0.12 |
| EBITDA(a) | $-9,467 | $-7,263 | $-7,626 | $-6,108 | $-5,057 |